Total submissions: 26
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
International Society for Gastrointestinal Hereditary Tumours |
RCV000030219 | SCV000106434 | no known pathogenicity | Lynch syndrome | 2013-09-05 | reviewed by expert panel | research | Synonymous substitution with no splicing aberration, >3 MSS CRC tumours, segregation LR <0.01 & MAF 0.01-1% |
Labcorp Genetics |
RCV000524259 | SCV000153861 | benign | Hereditary nonpolyposis colorectal neoplasms | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000153507 | SCV000170299 | benign | not specified | 2013-10-25 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Eurofins Ntd Llc |
RCV000153507 | SCV000203027 | benign | not specified | 2014-03-26 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000126778 | SCV000212672 | benign | Hereditary cancer-predisposing syndrome | 2016-10-25 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genomic Diagnostic Laboratory, |
RCV000030219 | SCV000257650 | benign | Lynch syndrome | 2015-07-22 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000126778 | SCV000292111 | benign | Hereditary cancer-predisposing syndrome | 2014-11-26 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000153507 | SCV000303147 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000610651 | SCV000744682 | benign | Colorectal cancer, hereditary nonpolyposis, type 2 | 2015-09-21 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV000610651 | SCV000745681 | benign | Colorectal cancer, hereditary nonpolyposis, type 2 | 2015-05-08 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001811212 | SCV001156602 | benign | not provided | 2023-11-17 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000610651 | SCV001305813 | uncertain significance | Colorectal cancer, hereditary nonpolyposis, type 2 | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
Sema4, |
RCV000126778 | SCV002528698 | benign | Hereditary cancer-predisposing syndrome | 2020-03-21 | criteria provided, single submitter | curation | |
Ce |
RCV001811212 | SCV002544786 | benign | not provided | 2024-08-01 | criteria provided, single submitter | clinical testing | MLH1: BP4, BP7, BS1, BS2 |
Center for Genomic Medicine, |
RCV000153507 | SCV002550460 | benign | not specified | 2023-08-15 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001811212 | SCV005238094 | benign | not provided | criteria provided, single submitter | not provided | ||
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000030219 | SCV000052886 | benign | Lynch syndrome | 2013-04-18 | no assertion criteria provided | clinical testing | |
Pathway Genomics | RCV000144610 | SCV000189937 | benign | Lynch syndrome 1 | 2014-07-24 | no assertion criteria provided | clinical testing | |
Mayo Clinic Laboratories, |
RCV000153507 | SCV000257075 | benign | not specified | no assertion criteria provided | clinical testing | ||
Department of Pathology and Laboratory Medicine, |
RCV001353935 | SCV000592429 | benign | Carcinoma of colon | no assertion criteria provided | clinical testing | The p.Leu653Leu variant is not expected to have clinical significance because it does not alter an amino acid residue and is not located near a splice junction. It is listed in dbSNP database as coming from a "clinical source" (ID#: rs1801426) with an average heterozygosity of 0.022+/-0.102, increasing the likelihood that this is a low frequency benign variant. The variant has been previously reported in the literature in 9 publications in 20 of 2288 proband chromosomes (frequency of 0.013) with colon cancer, breast cancer, prostate cancer and endometrial cancer, and was also identified in 39 of 2846 control chromosomes (frequency of 0.014), increasing the likelihood that this is a benign variant (Auclaire_16395668_2006, Buerstedde_ 8592341_1995, Christensen_18547406_2008, Fredriksson_16963262_2006, Kamory_14688830_2003, Lamberti_17095871_2006, Liu_9611074_1998, Scott_11112663_2001). In one report this variant was identified at a higher frequency in controls than in cases (Christensen_18547406_2008). In summary, based on the information above, this variant is classified as Benign. | |
Diagnostic Laboratory, |
RCV000610651 | SCV000734272 | likely benign | Colorectal cancer, hereditary nonpolyposis, type 2 | no assertion criteria provided | clinical testing | ||
True Health Diagnostics | RCV000126778 | SCV000788020 | likely benign | Hereditary cancer-predisposing syndrome | 2017-12-08 | no assertion criteria provided | clinical testing | |
Laboratory of Diagnostic Genome Analysis, |
RCV000153507 | SCV001798253 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics Laboratory, |
RCV000153507 | SCV001905719 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000153507 | SCV001920947 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000153507 | SCV001953573 | benign | not specified | no assertion criteria provided | clinical testing |